VBC103

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Participants With Advanced Solid Tumor Malignancies

Drug Information

Target Indication

Participants With Advanced Solid Tumor Malignancies

Clinical Trial

Last updated: 1/29/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

BIO

BIO-RAD LABORATORIES, INC.

Related Pipeline

Skin Structures and Soft Tissue Infections

Immunogenicity

Neovascular (Wet) Age-related Macular Degeneration

First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer

Anemia